Navigation Links
Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update
Date:11/17/2009

ROCKVILLE, Md., Nov. 17 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) today provided a financial and business update for the third quarter ended September 30, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO )

For the third quarter of 2009, the Company reported a net loss of $5,096,983, or $0.15 per share, compared with a net loss of $3,177,957 or $0.10 per share, for the comparable 2008 period. The increase was due to a non-cash charge related to a change in accounting for certain warrants, offset in part by reductions in other expense categories. Net loss attributable to common stockholders for the first nine months of 2009 was $7,380,751 or $0.22 per share, compared with $8,410,081, or $0.26 per share, for the comparable period in 2008, resulting from a year to date gain in accounting for warrants, partially offset by increases in non-cash stock-based compensation expense, R&D and legal fees.

Cash, cash equivalents and short-term marketable securities at September 30, 2009 totaled approximately $2.4 million, compared with approximately $4.9 million at December 31, 2008. As of September 30, 2009, the Company estimated that cash on hand would be sufficient to meet its operating needs into the first quarter of 2010, including estimated costs associated with the clinical trials for its ALS programs planned for commencement in the U.S. in 2010.

For the nine months ended September 30, 2009, cash used in operating activities totaled $3,613,084, a decrease of $1,118,358 or 24% compared to the same period in the prior year, primarily attributable to an increase of short term financing by vendors, employees and other service providers and a reduction in spending, particular
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Neuralstem, Inc.
2. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
3. Cadus Reports Third Quarter 2009 Results
4. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on November 16, 2009
5. Sinovac Reports Unaudited Third Quarter 2009 Financial Results
6. Soligenix Reports Third Quarter 2009 Financial Results
7. PharmAthene Reports Third Quarter 2009 Financial and Operational Results
8. Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization
9. Oncothyreon reports third quarter 2009 financial results & provides product pipeline update
10. China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates
11. YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (PRWEB) January 15, 2014 Cynvenio, a ... management through the genomic analysis of tumor cells in ... Finder™, a web-based cancer decision support application powered by ... with Cynvenio’s ClearID™ genomic test, Therapy Finder will provide ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 More than ... and about 1 in 3 seniors will die with ... ). These jaw-dropping figures have shocked many Americans into ... hopefully, help prevent these tragic age-related cognitive disorders. Jonathan ...
(Date:1/15/2014)... Freeslate, Inc ., the leading provider ... Limited, one of India’s top five pharmaceutical companies, has ... for high throughput solid form screening. , ... wide range of quality, affordable generic and branded formulations ...
(Date:1/14/2014)... San Diego, CA (PRWEB) January 14, 2014 ... based on the products of cells grown under simulated ... an international license agreement with Suneva Medical, Inc. for ... media (CCM). , This agreement is an ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... , , ST. JOSEPH, Mich., ... company, announced today that it launched a collaborative development project ... and leading academic centers as members. The 24-month project aims ... of different types of stem cells. The knowledge base will ...
... 1 According to a new,market research report, ,Global ... ), the,global autoimmune treatment market is expected to be ... 12.7% from 2009 to 2014. The North,American market is ... revenues. , Browse 100+ market ...
... ... the Center for Orthopedics in Sheffield Village, Ohio, just west of Cleveland, now offers ... for patients without an intact rotator cuff. Until now, these individuals -- who are ... live with the pain." , ...
Cached Biology Technology:GeneGo Kicks Off The MetaMiner Stem Cell Project With Industry and Academics 2MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014 2MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014 3MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014 4Robert Zanotti, MD, Is First Lorain County, Ohio Orthopedic Surgeon to Perform Reverse Total Shoulder Replacement 2Robert Zanotti, MD, Is First Lorain County, Ohio Orthopedic Surgeon to Perform Reverse Total Shoulder Replacement 3Robert Zanotti, MD, Is First Lorain County, Ohio Orthopedic Surgeon to Perform Reverse Total Shoulder Replacement 4
(Date:4/22/2014)... positive effects not only on weight loss but also ... Academy and University of Cincinnati have shown that the ... the stomach size but by increased levels of bile ... Nature , indicate that bile acids could be a ... research from the Sahlgrenska Academy has demonstrated that obesity ...
(Date:4/22/2014)... Most people think the development of the heart only ... birth are full of cellular changes that play a role ... models, researchers at Baylor College of Medicine have now been ... genes code proteins, determining their role) that takes place during ... The findings, which appear in Nature Communications , also ...
(Date:4/21/2014)... cows, which is commonly used as a farm soil ... resistance genes from the cows, gut bacteria. The findings, ... of the American Society for Microbiology, hints that cow ... antibiotic resistance genes that transfer to bacteria in the ... antibiotic resistance (AR) genes have already been identified, but ...
Breaking Biology News(10 mins):Researchers identify a mechanism linking bariatric surgery to health benefits 2Protein expression gets the heart pumping 2Cow manure harbors diverse new antibiotic resistance genes 2Cow manure harbors diverse new antibiotic resistance genes 3
... supplies are scarce in many areas of the United States, ... often regarded as the clean-burning energy source of the future ... previously thought. Their study appeared in ACS, journal Environmental ... out in the study that annual bioethanol production in the ...
... challenges the increasingly popular belief that smoking marijuana is ... Canada are reporting that smoking marijuana, like smoking tobacco, ... for the Aug. 17 issue of ACS, Chemical ... Maertens and colleagues note that people often view marijuana ...
... As the world,s environment ministers, government officials, diplomats ... Copenhagen in December 2009 to unite in the battle ... political deals the world has ever seen, the increasingly ... an article published today, 5 August, 2009, in IOP ...
Cached Biology News:Climate change poker: The barriers which are preventing a global agreement 2
... UNIchip AV-400 contains 400 unique ... nitrocellulose-coated glass slide. The proteins, all ... Ontology classification, are arrayed in quadruplicate ... and a specific chip layout guarantee ...
...
... stocks contained in standard 96-well microtiter plates. ... approximately 5,000 clones per plate. After positive ... the corresponding subplate is screened with a ... well(s). Cells from a positive well are ...
... The benchmark for analytical performance ... ease-of-use and the ultimate in ... Varian 810-MS features include: ... optics minimize,interferences, providing reliable, routine, ...
Biology Products: